Loading people...
Paul Ehlinger is a biomedical engineer turned startup operator and investor who supports early-stage companies across the health technology and biotechnology sectors. He holds a Bachelor of Science in Biomedical Engineering from the University of Missouri-Columbia and a Master of Science from the University of California, Riverside. Leveraging his formal academic training, he applies his technical engineering expertise to evaluate, advise, and scale emerging ventures within the broader life sciences ecosystem. Throughout his career, he has operated at the intersection of engineering and entrepreneurship, actively bridging the critical gap between complex scientific research and commercial startup operations. While his specific current corporate affiliations remain undisclosed, his professional activities center on identifying high-potential medical technologies. Ehlinger currently focuses on advising and investing in early-stage biomedical engineering startups that require specialized technical oversight to achieve long-term market viability.
Paul Ehlinger is Venture Partner at Sixty8 Capital, based in Cincinnati, OH, USA.